Source: Pharmacy Times articles
Subcutaneous immunoglobulin (SCIg) is a hopeful alternative to intravenous immunoglobulin in patients with inflammatory myositis due to a lack of adverse effects and fewer financial constraints.
Read More
by MM360 Staff | Jun 4, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Subcutaneous immunoglobulin (SCIg) is a hopeful alternative to intravenous immunoglobulin in patients with inflammatory myositis due to a lack of adverse effects and fewer financial constraints.
Read More